HomeCompareCFSIX vs JNJ

CFSIX vs JNJ: Dividend Comparison 2026

CFSIX yields 0.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CFSIX wins by $592.00 in total portfolio value
10 years
CFSIX
CFSIX
● Live price
0.67%
Share price
$17.83
Annual div
$0.12
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$69.74
Full CFSIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CFSIX vs JNJ

📍 CFSIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFSIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFSIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CFSIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFSIX
Annual income on $10K today (after 15% tax)
$56.76/yr
After 10yr DRIP, annual income (after tax)
$59.28/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $644.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFSIX + JNJ for your $10,000?

CFSIX: 50%JNJ: 50%
100% JNJ50/50100% CFSIX
Portfolio after 10yr
$20.3K
Annual income
$448.76/yr
Blended yield
2.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CFSIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFSIX buys
0
JNJ buys
0
No recent congressional trades found for CFSIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFSIXJNJ
Forward yield0.67%3.36%
Annual dividend / share$0.12$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.6K$20.0K
Annual income after 10y$69.74$827.78
Total dividends collected$684.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CFSIX vs JNJ ($10,000, DRIP)

YearCFSIX PortfolioCFSIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,767$66.78$10,676$355.77+$91.00CFSIX
2$11,588$67.20$11,407$389.39+$181.00CFSIX
3$12,466$67.59$12,198$426.53+$268.00CFSIX
4$13,407$67.96$13,056$467.62+$351.00CFSIX
5$14,414$68.30$13,987$513.12+$427.00CFSIX
6$15,491$68.63$14,998$563.56+$493.00CFSIX
7$16,645$68.93$16,098$619.52+$547.00CFSIX
8$17,879$69.22$17,295$681.69+$584.00CFSIX
9$19,200$69.49$18,599$750.82+$601.00CFSIX
10$20,614$69.74$20,022$827.78+$592.00CFSIX

CFSIX vs JNJ: Complete Analysis 2026

CFSIXStock

The fund invests, under normal market conditions, at least 80% of its assets in common stocks of U.S. companies that the sub-adviser, Sands Capital Management, LLC, believes have above-average potential for revenue or earnings growth. It emphasizes investments in large capitalization growth companies. The weighted-average market capitalization of these companies is generally in excess of $25 billion, and the fund generally does not invest in companies that have a market capitalization of less than $2 billion. The fund will typically own between 25 and 35 companies. It is non-diversified.

Full CFSIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CFSIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFSIX vs SCHDCFSIX vs JEPICFSIX vs OCFSIX vs KOCFSIX vs MAINCFSIX vs ABBVCFSIX vs MRKCFSIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.